Skinvisible (SKVI) Long-Term Deferred Tax (2018 - 2025)
Skinvisible's (SKVI) quarterly Long-Term Deferred Tax came in at $8.6 million in Q4 2025, up 2.38% year-over-year from $8.4 million in Q4 2024, and up 2.38% quarter-over-quarter from $8.4 million in Q4 2024.
Analysis
Skinvisible (SKVI) Long-Term Deferred Tax (2018 - 2025) Analysis & Trends
Skinvisible has disclosed Long-Term Deferred Tax across 8 years of filings, most recently posting $8.6 million for Q4 2025.
- In Q4 2025, Long-Term Deferred Tax rose 2.38% year-over-year to $8.6 million; the TTM figure through Dec 2025 stood at $8.6 million (up 2.38% YoY), while the FY2025 annual figure was $8.6 million, up 2.38% from the prior year.
- Long-Term Deferred Tax came in at $8.6 million for Q4 2025 at Skinvisible, up from $8.4 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $8.6 million in Q4 2025 to a low of $3.3 million in Q4 2021.
- Average Long-Term Deferred Tax over 5 years is $7.3 million, with a median of $8.3 million recorded in 2023.
- Year-over-year, Long-Term Deferred Tax surged 136.36% in 2022 and gained 1.2% in 2024.
- Over 5 years, Long-Term Deferred Tax stood at $3.3 million in 2021, then soared by 136.36% to $7.8 million in 2022, then increased by 6.41% to $8.3 million in 2023, then climbed by 1.2% to $8.4 million in 2024, then rose by 2.38% to $8.6 million in 2025.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $8.6 million in Q4 2025, $8.4 million in Q4 2024, and $8.3 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.60 Mn |
| Dec 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 8.30 Mn |
| Dec 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2019 | 2.80 Mn |
| Dec 31, 2018 | 2.70 Mn |